Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLoans and Notes ReceivablesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Xtant Medical Holdings (XTNT) Accumulated Depreciation & Amortization (2016 - 2025)

Xtant Medical Holdings has reported Accumulated Depreciation & Amortization over the past 15 years, most recently at $5.2 million for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 23.65% to $5.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.2 million through Dec 2025, up 23.65% year-over-year, with the annual reading at $5.2 million for FY2025, 23.65% up from the prior year.
  • Accumulated Depreciation & Amortization was $5.2 million for Q4 2025 at Xtant Medical Holdings, down from $21.9 million in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $21.9 million in Q3 2025 and troughed at $4.2 million in Q4 2024.
  • The 5-year median for Accumulated Depreciation & Amortization is $18.1 million (2022), against an average of $17.5 million.
  • Year-over-year, Accumulated Depreciation & Amortization crashed 78.54% in 2024 and then rose 23.65% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $17.2 million in 2021, then rose by 4.63% to $18.0 million in 2022, then rose by 9.55% to $19.7 million in 2023, then crashed by 78.54% to $4.2 million in 2024, then increased by 23.65% to $5.2 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Accumulated Depreciation & Amortization are $5.2 million (Q4 2025), $21.9 million (Q3 2025), and $21.2 million (Q2 2025).